Global Cloning and Mutagenesis Market Size study & Forecast, by Product, By Technology, By End user, and Regional Analysis, 2022-2029

Description

List of Tables

Global Cloning and Mutagenesis Market is valued at approximately USD 2.00 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.7% over the forecast period 2022-2029. Cloning is the process of creating naturally occurring or artificially produced, genetically identical copies of an organism. Mutagenesis is the process through which an organism's genetic composition is altered, leading to a mutation. In a laboratory context, mutagenesis is carried out when DNA is intentionally modified to produce mutant proteins, genes, or strains of an organism. Cloning and mutagenesis are two of the most effective methods created to research the links between protein structure and function. They are used to confirm the effects of mutations both in vitro and in vivo. Due to the growing use of cloning in numerous genetic applications, such as reproductive cloning, the global cloning and mutagenesis industry is expected to rise. The prevalence of hereditary and chronic diseases is expected to increase, as is the demand for personalized medicine. Due to growing financing for research and development targeted at curing genetic issues and other diseases, such as cancer and HIV, cloning and mutagenesis technologies are becoming more and more necessary.

The primary factors driving the global market are the rise in the prevalence of hereditary and chronic diseases, the rise in demand for personalized medicine, and the rise in new companies entering the industry. The industry's expansion is further aided by favorable funding conditions for gene synthesis and cloning services, technological advancements in the cloning industry, and an increase in commercial activities that work together well. Innovative, effective DNA and gene cloning services are being developed by top industry players. According to statista, nearly 17.9 million people worldwide passed away in 2019 as a result of cardiovascular disorders of all kinds. The number of deaths worldwide in 2019 attributable to a few chronic diseases is shown in this data. Chronic illness has negative effects on people's quality of life and lifespan, as well as on society and governments around the world. An enhancement in research and development can open up many opportunities. However, the side effects of cloning and mutation are restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Cloning and Mutagenesis Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, additionally, Cloning and mutagenesis methods are now used more frequently in the region as platforms built on genomic and proteomic data become more widely accepted. Greater product penetration in the region is due to the presence of top inventors and market players. In May 2021, Telesis Bio, Inc., a U.S. company, announced, for instance, that its BioXp technology now offers lengthy fragment cloning. With the help of this project, researchers may overnight hand-free clone into custom vectors and produce multivariant, error-corrected vectors.

Major market players included in this report are:

Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
New England Biolabs Inc.
Takara Bio Inc.
Merck KGaA
Promega Corporation
Bio-Rad Laboratories, Inc.
Danaher Corporation
Jena Bioscience GmbH
Assay Genie

Recent Developments in the Market:

In May 2021, the American company Telesis Bio, Inc. announced long fragment cloning is now supported by its BioXp technology. This project enables researchers to build multivariant, error-corrected vectors and hand-free overnight clone them into custom vectors.
In June 2019, The Human Glycome Project, a global endeavour to map the composition and function of human glycans, was announced by NEB, Waters, and Genos as a collaboration. To help with better sample preparation and process throughput, NEB will provide a variant of their Rapid PNGase F technology. In order to give its consumers access to illustrations of how its products are used in actual situations, NEB partnered with the artificial intelligence technology firm Bioz, Inc. in the same month.

Global Cloning and Mutagenesis Market Report Scope:

Historical Data 2019-2020-2021

Base Year for Estimation 2021

Forecast period 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Product, Technology, End User, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Cloning Kits
Mutagenesis Kits

By Technology:

Topo PCR Cloning
Blunt End Cloning
Seamless Cloning
Site-directed Mutagenesis
Others

By End User:

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Cloning and Mutagenesis Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Cloning and Mutagenesis Market, by Product, 2019-2029 (USD Billion)
- 1.2.3. Cloning and Mutagenesis Market, by Technology, 2019-2029 (USD Billion)
- 1.2.4. Cloning and Mutagenesis Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Cloning and Mutagenesis Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Cloning and Mutagenesis Market Dynamics

3.1. Cloning and Mutagenesis Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growing need for customised medicine
  - 3.1.1.2. rise in the frequency of inherited and chronic illnesses
  - 3.1.1.3. the growth in new businesses entering the market
- 3.1.2. Market Challenges
  - 3.1.2.1 The market growth is being constrained by the negative consequences of causing genetic disorder or cancer.
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increase in research & development
  - 3.1.3.2. Higher developments and recent advancements towards the formulation.

Chapter 4. Global Cloning and Mutagenesis Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cloning and Mutagenesis Market, by Product

6.1. Market Snapshot
6.2. Global Cloning and Mutagenesis Market by Product ,Performance - Potential Analysis
6.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by Product2019-2029 (USD Billion)
6.4. Cloning and Mutagenesis Market, Sub Segment Analysis
- 6.4.1. Cloning kits
- 6.4.2. Mutagenesis kits

Chapter 7. Global Cloning and Mutagenesis Market, by Technology

7.1. Market Snapshot
7.2. Global Cloning and Mutagenesis Market by Technology, Performance - Potential Analysis
7.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
7.4. Cloning and Mutagenesis Market, Sub Segment Analysis
- 7.4.1. Topo PCR Cloning
- 7.4.2. Blunt End Cloning
- 7.4.3. Seamless Cloning
- 7.4.4. Site directed Cloning
- 7.4.5. Others

Chapter 8. Global Cloning and Mutagenesis Market, by End User

8.1. Market Snapshot
8.2. Global Cloning and Mutagenesis Market by End user, Performance - Potential Analysis
8.3. Global Cloning and Mutagenesis Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
8.4. Cloning and Mutagenesis Market, Sub Segment Analysis
- 8.4.1. Biopharmaceutical & Pharmaceutical companies
- 8.4.2. CROs & CMOs
- 8.4.3. Academic & Research Institutes

Chapter 9. Global Cloning and Mutagenesis Market, Regional Analysis

9.1. Cloning and Mutagenesis Market, Regional Market Snapshot
9.2. North America Cloning and Mutagenesis Market
- 9.2.1. U.S. Cloning and Mutagenesis Market
  - 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
  - 9.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
  - 9.2.1.3. End user breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Cloning and Mutagenesis Market
9.3. Europe Cloning and Mutagenesis Market Snapshot
- 9.3.1. U.K. Cloning and Mutagenesis Market
- 9.3.2. Germany Cloning and Mutagenesis Market
- 9.3.3. France Cloning and Mutagenesis Market
- 9.3.4. Spain Cloning and Mutagenesis Market
- 9.3.5. Italy Cloning and Mutagenesis Market
- 9.3.6. Rest of Europe Cloning and Mutagenesis Market
9.4. Asia-Pacific Cloning and Mutagenesis Market Snapshot
- 9.4.1. China Cloning and Mutagenesis Market
- 9.4.2. India Cloning and Mutagenesis Market
- 9.4.3. Japan Cloning and Mutagenesis Market
- 9.4.4. Australia Cloning and Mutagenesis Market
- 9.4.5. South Korea Cloning and Mutagenesis Market
- 9.4.6. Rest of Asia Pacific Cloning and Mutagenesis Market
9.5. Latin America Cloning and Mutagenesis Market Snapshot
- 9.5.1. Brazil Cloning and Mutagenesis Market
- 9.5.2. Mexico Cloning and Mutagenesis Market
- 9.5.3. Rest of Latin America Cloning and Mutagenesis Market
9.6. Rest of The World Cloning and Mutagenesis Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies
10.2. Company Profiles
- 10.2.1. Agilent Technologies, Inc
  - 10.2.1.1. Key Information
  - 10.2.1.2. Overview
  - 10.2.1.3. Financial (Subject to Data Availability)
  - 10.2.1.4. Product Summary
  - 10.2.1.5. Recent Developments
- 10.2.2. Agilent Technologies, Inc
- 10.2.3. New England Biolabs Inc.
- 10.2.4. Takara Bio Inc.
- 10.2.5. Merck KGaA
- 10.2.6. Promega Corporation
- 10.2.7. Bio-Rad Laboratories Inc.
- 10.2.8. Danaher Corporation
- 10.2.9. Jena Bioscience GmbH
- 10.2.10. Assay Genie

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Cloning and Mutagenesis Market, report scope
TABLE 2. Global Cloning and Mutagenesis Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Cloning and Mutagenesis Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Cloning and Mutagenesis Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 5. Global Cloning and Mutagenesis Market estimates & forecasts by End user 2019-2029 (USD Billion)
TABLE 6. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Cloning and Mutagenesis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Cloning and Mutagenesis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Cloning and Mutagenesis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Cloning and Mutagenesis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Cloning and Mutagenesis Market
TABLE 71. List of primary sources, used in the study of global Cloning and Mutagenesis Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Cloning and Mutagenesis Market, research methodology
FIG 2. Global Cloning and Mutagenesis Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cloning and Mutagenesis Market, key trends 2021
FIG 5. Global Cloning and Mutagenesis Market, growth prospects 2022-2029
FIG 6. Global Cloning and Mutagenesis Market, porters 5 force model
FIG 7. Global Cloning and Mutagenesis Market, pest analysis
FIG 8. Global Cloning and Mutagenesis Market, value chain analysis
FIG 9. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Cloning and Mutagenesis Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Cloning and Mutagenesis Market, regional snapshot 2019 & 2029
FIG 15. North America Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
FIG 16. Europe Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Cloning and Mutagenesis Market 2019 & 2029 (USD Billion)
FIG 19. Global Cloning and Mutagenesis Market, company Market share analysis (2021)